Editorial: Governor’s effort to lower insulin prices is a smart investment

  • 📰 mercnews
  • ⏱ Reading Time:
  • 28 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 68%

Finance Finance Headlines News

Finance Finance Latest News,Finance Finance Headlines

Creating a public market could break greedy drugmakers stranglehold on Type 1 diabetes patients

Gavin Newsom is taking aim at the three greedy insulin drugmakers who have made billions in profits at the expense of Californians with Type 1 diabetes who must take the medication every day to survive.

Newsom believes the state can help patients who now pay out of pocket thousands of dollars a year. While it won’t be easy, he deserves credit for trying to break the oligopoly that’s making basic prescription drugs unaffordable. In January, the 4 million American seniors on Medicare with Type 1 diabetes saw their insulin costs capped at $35 per month, thanks to government subsidies from the Inflation Reduction Act. In February, in his State of the Union address, President Biden called on Congress to extend that benefit to all Americans.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 88. in FİNANCE

Finance Finance Latest News, Finance Finance Headlines